Katodritou Eirini, Kartsios Charalambos, Gastari Vassiliki, Verrou Evgenia, Mihou Dimitra, Banti Anastasia, Lazaraki Georgia, Lazaridou Anna, Kaloutsi Vassiliki, Zervas Konstantinos
Theagenion Cancer Center, Hematology, Eyrygeni 6B, 54249 Thessaloniki, Greece.
Leuk Res. 2008 Feb;32(2):339-41. doi: 10.1016/j.leukres.2007.04.016. Epub 2007 Jun 8.
We report a case of a 68-year-old man presented with upper-gastrointestinal bleeding. Endoscopy showed a large ulcerated gastric mass. Histological examination of the gastric biopsies revealed a k monoclonal extramedullary plasmacytoma (EMP). Further staging was negative for multiple myeloma. The patient was managed with bortezomib at a dose of 1.3mg/m2 on days 1, 4, 8 and 11 of a 21-day cycle in combination with dexamethasone 20mg p.o. on days 1, 2, 4, 5, 8, 9 and 11, 12 of each cycle. After 4 cycles of treatment, no endoscopic or histological findings of EMP were found. Thirteen months after diagnosis the patient is in complete remission with no evidence of local relapse or evolution to multiple myeloma. This is the first reported case of EMP successfully managed with the combination of bortezomib and dexamethasone.
我们报告一例68岁男性患者,出现上消化道出血。内镜检查显示胃内有一个大的溃疡性肿物。胃活检组织学检查显示为κ单克隆髓外浆细胞瘤(EMP)。进一步分期显示多发性骨髓瘤为阴性。患者接受硼替佐米治疗,剂量为1.3mg/m²,在21天周期的第1、4、8和11天给药,同时联合地塞米松,每次周期的第1、2、4、5、8、9、11和12天口服20mg。经过4个周期的治疗,未发现EMP的内镜或组织学表现。诊断后13个月,患者完全缓解,无局部复发或进展为多发性骨髓瘤的证据。这是首例报道的采用硼替佐米和地塞米松联合成功治疗的EMP病例。